Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kyle Ring
Observed name:
Ring, Kyle
Institutions:
Queen Mary University of London,
Barts Health NHS Trust,
Blizard Institute
Observed institutions:
National Health Service,
Imperial College Healthcare NHS Trust,
Queen Mary University of London,
Barts Health NHS Trust,
St Mary's Hospital,
Blizard Institute,
Imperial College London
show all 7
ORCID:
0000-0003-4016-4643
Observed ORCID:
0000-0003-4016-4643
OpenAlex ID:
A5091060158
Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV
2022
·
Rachel K.Y. Hung
, Elizabeth Binns-Roemer
, et al.
·
Kidney International Reports
·
33
PDF
Clinical outcomes of patients with and without HIV hospitalized with COVID‐19 in England during the early stages of the pandemic: a matched retrospective multi‐centre analysis (RECEDE‐C19 study)
2021
·
Ming Jie Lee
, Luke Blagdon Snell
, et al.
·
HIV Medicine
·
28
PDF
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process
2025
·
Chloe Orkin
, Amy Paterson
, et al.
·
The Lancet HIV
·
22
PDF
Long‐acting injectable cabotegravir and rilpivirine in observational cohort studies: A systematic review on virological failure, resistance and re‐suppression outcomes in virally suppressed individuals living with HIV
2025
·
Kyle Ring
, Alexa Elias
, et al.
·
HIV Medicine
·
22
PDF
Multicentre service evaluation of injectable cabotegravir and rilpivirine delivery and outcomes across 12 UK clinics ( SHARE LAI ‐net)
2024
·
Kyle Ring
, Melanie Smuk
, et al.
·
HIV Medicine
·
21
PDF
Perspectives of People With HIV on Implementing Long-acting Cabotegravir Plus Rilpivirine in Clinics and Community Settings in the United Kingdom: Results From the Antisexist, Antiracist, Antiageist Implementing Long-acting Novel Antiretrovirals Study
2024
·
Chloe Orkin
, Rosalie Hayes
, et al.
·
Clinical Infectious Diseases
·
20
Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions
2025
·
Anna Maria Geretti
, Marta Boffito
, et al.
·
Open Forum Infectious Diseases
·
17
PDF
Time to HIV rebound after infusion of long-acting broadly neutralising antibodies 3BNC117-LS and 10-1074-LS and analytical treatment interruption (the RIO trial): a double-blind, randomised, placebo-controlled trial
2026
·
Ming Jie Lee
, Louise-Rae Cherrill
, et al.
·
The Lancet HIV
·
16
T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy
2026
·
Mohammed Altaf
, Carla Nel
, et al.
·
medRxiv
·
12
PDF
Sickle Cell Trait and Kidney Disease in People of African Ancestry With HIV
2021
·
Rachel K.Y. Hung
, Elizabeth Binns-Roemer
, et al.
·
Kidney International Reports
·
10
PDF
Switch to once-weekly, single-tablet islatravir–lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial
2026
·
Amy E Colson
, Princy N Kumar
, et al.
·
The Lancet
·
9
Long-acting antiretroviral therapy in the context of viral suppression
2024
·
Kyle Ring
, Chloe Orkin
·
Current Opinion in HIV and AIDS
·
9
Contact tracing for SARS-CoV-2: what can be learned from other conditions?
2021
·
James Brown
, Kyle Ring
, et al.
·
Clinical Medicine
·
7
PDF
Implementing long-acting injectable cabotegravir and rilpivirine in Africa
2024
·
Chloe Orkin
, Kyle Ring
·
The Lancet Infectious Diseases
·
4
HIV-1 superinfection in a patient with known HIV-2 – A case report
2020
·
Kyle Ring
, David Muir
, et al.
·
International Journal of STD & AIDS
·
4
GSTM1 Copy Number and Kidney Disease in People With HIV
2022
·
Rachel K.Y. Hung
, Kerry-Lee Rosenberg
, et al.
·
Kidney International Reports
·
3
PDF
APOL1 Variants, AKI, and Progression to Kidney Failure in People of African Ancestry Living with HIV
2026
·
Rachel K.Y. Hung
, John W. Booth
, et al.
·
Kidney International Reports
·
1
PDF
Estimation of cancer cases in transgender and gender diverse people in England
2026
·
Chloé Pasin
, Sarah S Jackson
, et al.
·
medRxiv
·
1
PDF
Exploring pronoun use amongst HIV and sexual health clinic staff in the UK: A mixed methods analysis
2025
·
Kyle Ring
, Melanie Smuk
, et al.
·
International Journal of Transgender Health
·
1
PDF
Clinical Outcomes of Patients With and Without HIV Hospitalised with COVID-19 in England During the Early Stages of the Pandemic: A Matched Retrospective Multicentre Analysis (RECEDE-C19 Study)
2021
·
Ming Lee
, Colette J Smith
, et al.
·
SSRN Electronic Journal
·
1
Participant experiences of stopping ART as part of a clinical trial; findings from a qualitative study within the RIO trial in the United Kingdom
2026
·
Jesal Gohil
, Marcelino Molina
, et al.
·
HIV Research & Clinical Practice
PDF
The contingency of PrEP engagement: perspectives of underserved populations in the United Kingdom in the PrEP-Position mixed-methods study
2026
·
Sara Paparini
, Vian Rajabzadeh
, et al.
·
Research Square
PDF
Perspectives of healthcare providers on differentiated service delivery of long-acting cabotegravir and rilpivirine in clinics and community settings in England: findings from the ILANA non-randomised implementation study
2026
·
Rosalie Hayes
, Sara Paparini
, et al.
·
Research Square
PDF
Comment on: Clinical and serological outcomes in patients treated with oral doxycycline for early neurosyphilis
2021
·
Kyle Ring
, Fareed Shiva
·
Journal of Antimicrobial Chemotherapy
Show more works
View as search
Works count:
25
Citation count:
241
H-index:
10
I10-index:
10
Year
Topic
Type